Penserra Capital Management LLC Ptc Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$35.36 - $41.86 $57,106 - $67,603	-1,615 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $370 - $447	10 Added 0.62%	1,615 $60,000
Q2 2021 Aug 12, 2021	BUY	$37.95 - $49.37 $569 - $740	15 Added 0.94%	1,605 $67,000
Q1 2021 May 13, 2021	BUY	$46.8 - $68.92 $1,170 - $1,723	25 Added 1.6%	1,590 $75,000
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $47,336 - $66,760	987 Added 170.76%	1,565 $95,000
Q3 2020 Nov 13, 2020	BUY	$45.41 - $57.07 $26,246 - $32,986	578 New	578 $27,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.